formoterol fumarate has been researched along with Asthma, Bronchial in 4 studies
N-[2-hydroxy-5-(1-hydroxy-2-{[1-(4-methoxyphenyl)propan-2-yl]amino}ethyl)phenyl]formamide : A phenylethanoloamine having 4-hydroxy and 3-formamido substituents on the phenyl ring and an N-(4-methoxyphenyl)propan-2-yl substituent.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bouyssou, T | 1 |
Rudolf, K | 1 |
Hoenke, C | 1 |
Lustenberger, P | 1 |
Schnapp, A | 1 |
Konetzki, I | 1 |
Glossop, PA | 1 |
Lane, CA | 1 |
Price, DA | 1 |
Bunnage, ME | 1 |
Lewthwaite, RA | 1 |
James, K | 1 |
Brown, AD | 1 |
Yeadon, M | 1 |
Perros-Huguet, C | 1 |
Trevethick, MA | 1 |
Clarke, NP | 1 |
Webster, R | 1 |
Jones, RM | 1 |
Burrows, JL | 1 |
Feeder, N | 1 |
Taylor, SC | 1 |
Spence, FJ | 1 |
Alcaraz, L | 1 |
Bailey, A | 1 |
Cadogan, E | 1 |
Connolly, S | 1 |
Jewell, R | 1 |
Jordan, S | 1 |
Kindon, N | 1 |
Lister, A | 1 |
Lawson, M | 1 |
Mullen, A | 1 |
Dainty, I | 1 |
Nicholls, D | 1 |
Paine, S | 1 |
Pairaudeau, G | 1 |
Stocks, MJ | 1 |
Thorne, P | 1 |
Young, A | 1 |
McKinnell, RM | 1 |
Klein, U | 1 |
Linsell, MS | 1 |
Moran, EJ | 1 |
Nodwell, MB | 1 |
Pfeiffer, JW | 1 |
Thomas, GR | 1 |
Yu, C | 1 |
Jacobsen, JR | 1 |
4 other studies available for formoterol fumarate and Asthma, Bronchial
Article | Year |
---|---|
Studies towards topical selective beta2-adrenoceptor agonists with a long duration of action.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Animals; Asthma; Bronchodi | 2009 |
Inhalation by design: novel ultra-long-acting β(2)-adrenoreceptor agonists for inhaled once-daily treatment of asthma and chronic obstructive pulmonary disease that utilize a sulfonamide agonist headgroup.
Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Animals; | 2010 |
From libraries to candidate: the discovery of new ultra long-acting dibasic β₂-adrenoceptor agonists.
Topics: Adrenergic beta-Agonists; Animals; Asthma; Bronchodilator Agents; Cell Line, Tumor; Chemistry, Pharm | 2012 |
Discovery of TD-4306, a long-acting β2-agonist for the treatment of asthma and COPD.
Topics: Adrenergic beta-2 Receptor Agonists; Animals; Asthma; Cell Line; Diphenylamine; Disease Models, Anim | 2014 |